Calamos Advisors LLC Tela Bio, Inc. Transaction History

Calamos Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$5.3 - $7.61 $11,628 - $16,696	-2,194 Reduced 6.1%	33,776 $191,000
Q4 2023 Jan 31, 2024	SELL	$4.5 - $7.51 $128,767 - $214,898	-28,615 Reduced 44.31%	35,970 $238,000
Q3 2023 Oct 25, 2023	SELL	$7.85 - $10.68 $144,981 - $197,248	-18,469 Reduced 22.24%	64,585 $516,000
Q2 2023 Jul 28, 2023	BUY	$9.23 - $11.23 $611,155 - $743,583	66,214 Added 393.19%	83,054 $841,000
Q1 2023 May 03, 2023	BUY	$9.41 - $12.03 $61,277 - $78,339	6,512 Added 63.05%	16,840 $179,000
Q4 2022 Jan 25, 2023	SELL	$6.5 - $11.5 $265,148 - $469,108	-40,792 Reduced 79.8%	10,328 $0
Q3 2022 Oct 24, 2022	BUY	$7.36 - $9.15 $376,243 - $467,748	51,120 New	51,120 $436,000

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $51.7M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.